877133-56-7

Basic information

• Product Name: 2-chloro-5-(MethoxyMethoxy)pyridine
• Synonyms: 2-chloro-5-(MethoxyMethoxy)pyridine
• CAS NO: 877133-56-7
• Molecular Formula: C₇H₈ClNO₂
• Molecular Weight: 173.59692
• EINECS: -0
• Mol File: 877133-56-7.mol
• Article Data: 18

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-chloro-5-(MethoxyMethoxy)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-5-(MethoxyMethoxy)pyridine(877133-56-7)
• EPA Substance Registry System: 2-chloro-5-(MethoxyMethoxy)pyridine(877133-56-7)

Safety Data

• Hazardous Substances Data: 877133-56-7(Hazardous Substances Data)

Usage

General Description

2-chloro-5-(MethoxyMethoxy)pyridine is a chemical compound with the molecular formula C7H8ClNO2. It is a chlorinated pyridine derivative with a methoxymethoxy group attached to the 5-position of the pyridine ring. 2-chloro-5-(MethoxyMethoxy)pyridine has potential applications in the pharmaceutical and agrochemical industries due to its unique structure and properties. It can be used as a building block in the synthesis of various organic compounds and may exhibit biological activity that could be useful in drug development or crop protection. Additionally, its chlorinated and methoxymethoxy functional groups make it a versatile starting material for the development of novel chemicals and materials. Overall, 2-chloro-5-(MethoxyMethoxy)pyridine has potential as a valuable intermediate in the synthesis of various useful compounds for different industries.

Upstream product

• 41288-96-4 6-chloropyridine-3-ol 
• 13057-17-5 bromethyl methyl ether 
• 107-30-2 chloromethyl methyl ether 

Downstream Products

• 877133-57-8 2-chloro-4-iodo-5-(methoxymethoxy)pyridine 
• 1060804-53-6 2-chloro-5-hydroxypyridine-4-carbaldehyde 
• 1315362-16-3 methyl 5-chlorofuro[2.3-c]pyridine-2-carboxylate 
• 1454285-47-2 5-chlorofuro[2,3-c]pyridine-2-carboxylic acid 
• 1454285-48-3 N-[[4-(benzenesulfonyl)phenyl]methyl]-5-chlorofuro[2,3-c]pyridine-2-carboxamide 
• 1454285-49-4 N-[[4-(benzenesulfonyl)phenyl]methyl]-5-[(diphenylmethylidene)amino]furo[2.3-c]pyridine-2-carboxamide 
• 1454285-13-2 5-amino-N-[[4-(benzenesulfonyl)phenyl]methyl]furo[2,3-c]pyridine-2-carboxamide 
• 1445968-07-9 2-chloro-5-hydroxyisonicotinonitrile 
• 1606121-69-0 2-(3-fluorophenyl)-5-(methoxymethoxy)pyridine 
• 1606121-70-3 (2-(3-fluorophenyl)-5-hydroxypyridin-4-yl)boronic acid 
• 1441754-60-4 5-(2-chloro-5-methoxy-pyridin-4-yl)-4-(4-chloro-2-methyl-phenyl)-3-isopropyl-2-(2-methoxy-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one 
• 1211516-07-2 2-chloro-4-iodo-5-methoxy-pyridine 
• 877133-58-9 6-chloro-4-iodo-pyridin-3-ol 
• 861966-16-7 4-(5-hydroxypyridin-2-yl)piperazine-1-carboxylic acid benzyl ester 

Relevant articles and documents

TETRAHYDROBENZO-QUINOLINE SULFONAMIDES DERIVATIVE COMPOUNDS

The present invention relates to tetrahydrobenzo-isoquinoline sulfonamides derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use in treating disorders caused by IgE (such as allergic responses,

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR

Disclosed are heterocyclic compounds as inhibitors of FGFR-4 represented by formula (I). Also disclosed is a pharmaceutical composition that includes an inhibitor of FGFR-4. The compounds maybe used to treat diseases mediated with abnormality of FGFR-4 and /or FGF19, such as hepatocellular carcinoma and other forms of cancer.

CONDENSED TRICYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

There is provided compounds of formula I, (I) wherein R1, R2, R3 R4, R5, R6, R7a and R7b have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. CDK8 and/or Haspin kinase) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.